Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): GEM Weekly (9 Dec 2022): China Inflation and more

In today’s briefing:

  • GEM Weekly (9 Dec 2022): China Inflation, South Africa GDP; JD Logistics, SEC, Naver, TSMC, NetEase
  • China Healthcare Weekly (Dec.9) – COVID Policy Update, Biotech Growth Curve, HKEX Chapter 18A Review

GEM Weekly (9 Dec 2022): China Inflation, South Africa GDP; JD Logistics, SEC, Naver, TSMC, NetEase

By Wium Malan, CFA


China Healthcare Weekly (Dec.9) – COVID Policy Update, Biotech Growth Curve, HKEX Chapter 18A Review

By Xinyao (Criss) Wang

  • China further optimized COVID policy. The main reason to ease the policy at this time could be to release risks in advance so as to recover as soon as possible.
  • The growth curve of biotech is not linear. We analyzed three situations to help investors better understand “the new story” of Biotech at different stages.
  • We reviewed the performance of Company listed under HKEX Chapter 18A since this year. We found some interesting points worth the attention.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars